Ankyrin brain (ANK2) Mouse Monoclonal Antibody [Clone ID: N105/17]

CAT#: 75-145

Ankyrin brain (ANK2) mouse monoclonal antibody, clone N105/17

Product Images

Adult rat brain membrane immunoblot

• 

  Adult rat hippocampus immunohistochemistry

• 

  immunoblot against crude C. elegans worm extracts and brain membranes from adult rat (RBM) probed with N105/17 TC supe.

• 

  immunoblot against crude membranes prepared from whole rat (RBM) and mouse (MBM) brain, and from human hippocampus [HBM(H)], cerebral cortex [HBM(Cx)] and cerebellum [HBM(Cb)] probed with N105/17 TC supe.

Specifications

Product Data

• Clone Name: N105/17
• Applications: IF, IHC, WB
• Recommended Dilution: Immunoblot (IB).
  Immunohistochemistry (IHC).
  Immunocytochemistry (ICC).
• Reactivities: Human, Mouse, Rat
• Host: Mouse
• Isotype: IgG2a
• Clonality: Monoclonal
• Immunogen: Fusion protein amino acids 203-496 (ankyrin repeats 6 to 14) of human Ankyrin-B (also known as Ankyrin-2, Brain ankyrin, Non-erythroid Ankyrin and ANK2, accession number Q01484).
  Mouse: 99% identity (292/294 amino acids identical).
  Rat: 98% identity (291/294 amino acids identical).
  ~80% identity with Ankyrin-G.
• Specificity: Does not cross-react with Ankyrin-G
• Formulation: State: Purified
• Conjugation: Unconjugated
• Gene Name: ankyrin 2, neuronal
• Database Link:
  Entrez Gene 287 Human
  UniProt ID Q01484
• Synonyms: Brain ankyrin, Ankyrin-B, ANK2
• Note: USERS will cite the UC Davis/NIH NeuroMab Facility in any publication(s) describing the research utilizing the MATERIALS. The suggested acknowledgment statement is as follows:
  "The monoclonal antibody _ was developed by and/or obtained from the UC Davis/NIH NeuroMab Facility, supported by NIH grant U24NS050606 and maintained by the Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, CA 95616."
  Also, please include the complete clone number (e.g., N52A/42) and the Antibody Registry identification number (e.g., RRID:AB_2120479) to avoid ambiguity.
  View Research License Agreement